Vapi (Gujarat)-based manufacturer of Anti-Malarial, Anti-Retroviral and other APIs, and among the world's largest suppliers of Anti-Malarial active pharmaceutical ingredients.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|
| LiabilitiesEquity Capital | 16 | 16 | 16 | 16 |
| Reserves | 120 | 133 | 112 | 87 |
| Borrowings | 107 | 96 | 95 | 105 |
| Other Liabilities | 91 | 121 | 94 | 106 |
| Total Liabilities | 334 | 366 | 317 | 315 |
| AssetsFixed Assets | 148 | 163 | 159 | 159 |
| CWIP | 8 | 3 | 4 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 178 | 201 | 155 | 156 |
| Total Assets | 334 | 366 | 317 | 315 |
| Line item | FY24 | FY25 | FY26 |
|---|---|---|---|
| ActivitiesCash from Operating | 4 | 43 | 4 |
| Cash from Investing | -12 | -19 | -12 |
| Cash from Financing | 5 | -22 | 6 |
| SummaryCapital Expenditure | — | — | — |
| Free Cash Flow | -8 | 23 | -8 |
| FCF Margin | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
MANGALAM · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.